Overview

A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test if olopatadine punctal plugs can reduce the symptoms (itching) of allergic conjunctivitis to ragweed in an Environmental Exposure Chamber model.

Phase:

Phase 2

Details

Lead Sponsor:

Mati Therapeutics Inc.

Treatments:

Olopatadine Hydrochloride